TiGenix NV (TIG) Reaches $42.05 52-Week High; Monsanto Co (MON)’s Sentiment Is 0.84

January 17, 2018 - By Darrin Black

Monsanto Company, together with its subsidiaries, provides agricultural products for farmers worldwide. The company has market cap of $52.55 billion. It operates in two divisions, Seeds and Genomics, and Agricultural Productivity. It has a 22.12 P/E ratio. The Seeds and Genomics segment produces row crop seeds, including corn, soybean, cotton, and canola seeds under the DEKALB, Channel, Asgrow, and Deltapine brands; and vegetable seeds, such as tomato, pepper, melon, cucumber, squash, beans, broccoli, onions, lettuce, and others under the Seminis and De Ruiter brands.

The stock of TiGenix NV (NASDAQ:TIG) hit a new 52-week high and has $45.41 target or 8.00% above today’s $42.05 share price. The 9 months bullish chart indicates low risk for the $976.62 million company. The 1-year high was reported on Jan, 17 by Barchart.com. If the $45.41 price target is reached, the company will be worth $78.13 million more. The stock increased 0.48% or $0.2 during the last trading session, reaching $42.05. About 10,280 shares traded. TiGenix NV (NASDAQ:TIG) has 0.00% since January 17, 2017 and is . It has underperformed by 16.70% the S&P500.

TiGenix NV, a biopharmaceutical company, develops and commercializes therapeutics from its proprietary technology platforms of allogeneic or donor derived stem cells. The company has market cap of $976.62 million. The Company’s stem cell programs are based on proprietary validated platforms of allogeneic expanded stem cells targeting autoimmune, inflammatory, and heart diseases. It currently has negative earnings. The companyÂ’s lead product candidate is the Cx601, which completed Phase III clinical trials for the treatment of complex perianal fistulas in patients suffering from CrohnÂ’s disease.

Ratings analysis reveals 60% of Monsanto’s analysts are positive. Out of 5 Wall Street analysts rating Monsanto, 3 give it “Buy”, 0 “Sell” rating, while 2 recommend “Hold”. The lowest target is $102.2 while the high is $128.0. The stock’s average target of $116.07 is -2.64% below today’s ($119.22) share price. MON was included in 6 notes of analysts from September 15, 2016. The company was upgraded on Monday, September 26 by Bernstein. The company was upgraded on Friday, January 6 by CLSA. As per Wednesday, September 21, the company rating was upgraded by JP Morgan. The firm has “Buy” rating given on Thursday, September 15 by Deutsche Bank. The rating was initiated by RBC Capital Markets on Thursday, February 23 with “Sector Perform”.

The stock decreased 0.42% or $0.5 during the last trading session, reaching $119.22. About 622,150 shares traded. Monsanto Company (MON) has risen 15.46% since January 17, 2017 and is uptrending. It has underperformed by 1.24% the S&P500.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: